Use of Selincro and Impact on Usual Practice

• Status: Completed
• Trial end date: 2018-04-01
• Target enrollment: 0
• Participant gender: All

Summary

USE-PACT is a cohort study of patients initiating Selincro® with one-year follow-up, performed using a random sample of prescribers. The aim of the study is to evaluate the use of Selincro in real-life and its impact on alcohol consumption at one year.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Bordeaux
• Collaborator: Lundbeck France
• Treatments: Nalmefene; Naltrexone

Criteria

Inclusion Criteria:

• Adult patient (≥18 years) initiating Selincro

• Patient accepting to participate

• Patient without linguistic barrier, notably to read the information letter and to complete the self-administrated questionnaires

• Patient not included in another study susceptible to modify patient care

• Patient not under a guardianship

Exclusion Criteria:

• Minor patient (≤18 years)

• Patient refusing to participate

• Patient with linguistic barrier

• Patient included in another study susceptible to modify patient care

• Patient under a guardianship